Obermatt
See Similar Stocks →

Flags

Financial distress

Gevo

NAQ:GEVO · US3743964062
Oil, Gas & Consumable FuelsSmall

360

17
Profit price83
Owner Earnings Yield1
Dividend Yield1
Price/Sales85
EV / Gross Profit45
Price/Book71
Return on Capital29
Cash Return on Capital32
Return on Equity31
EBIT Margin25
Gross Profitability60
Accruals40
Owner Earnings Margin27
Sales growth70
Profit growth39
Reinvestment39
Price momentum56
Debt load34
Refinancing87
Debt Payback1
Liquidity74
Analyst ratings21
Opinion Changes50
Price Target Upside100
Market mood40
Value Creation6/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Gevo doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryOil, Gas & Consumable Fuels
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded2005
Employees109
Websitegevo.com
ISINUS3743964062
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Anaerobic DigestionClimateTechClean EnergyCleanTechBiofuelCarbon Capture, Utilisation & Sequestration (CCUS) or (CCS)Onshore and Offshore WindSustainable Aviation Fuel (SAF)EnergyFossil FuelsFuelRenewable Energy

Description

Gevo, Inc. (Gevo) is a growth-oriented, carbon abatement company. The company focuses on hard to decarbonize market sectors, such as jet fuel, certain specialty fuels, on-road fuels, chemicals and materials, and certain products for the food chain,…

Analysis

Middle-of-the-road

Gevo, Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is stretched. The company scores 6/20 on our value-creation score: not creating value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
66
2026

All-time high

69

Mar 2026

All-time low

66

Jun 2026

Average rank

68

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
85
—
—
—
Price/Earnings
97
—
—
—
Price/Book
71
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
71
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Gevo with its peers
Sotera Health
NSQ:SHC
59
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
Cullinan Therapeutics
NSQ:CGEM
61
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
eXoZymes
NAQ:EXOZ
—
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Recursion Pharmaceuticals
NSQ:RXRX
20
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Unicycive Therapeutics
NAQ:UNCY
85
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Labcorp
NYQ:LH
40
CountryUSA
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →